- $10.96bn
- $12.51bn
- $3.65bn
- 97
- 36
- 97
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,854 | 2,720 | 2,867 | 3,272 | 3,651 |
Cost of Revenue | |||||
Gross Profit | 1,252 | 1,184 | 1,205 | 1,322 | 1,582 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,319 | 2,316 | 2,337 | 2,693 | 2,942 |
Operating Profit | 535 | 404 | 530 | 579 | 708 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 475 | 365 | 524 | 515 | 617 |
Provision for Income Taxes | |||||
Net Income After Taxes | 402 | 315 | 483 | 458 | 541 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 402 | 314 | 483 | 458 | 540 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 402 | 314 | 483 | 458 | 540 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.75 | 4.94 | 5.43 | 5.62 | 6.53 |
Dividends per Share |